Vigil Neuroscience (VIGL) Short Interest Ratio & Short Volume → Trump Asset Seizure Threat Alert: Could Your Savings Be Next? (From American Hartford Gold Group) (Ad) Free VIGL Stock Alerts $3.68 -0.10 (-2.65%) (As of 09:30 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestSocial Media Vigil Neuroscience Short Interest DataCurrent Short Volume921,000 sharesPrevious Short Volume987,900 sharesChange Vs. Previous Month-6.77%Dollar Volume Sold Short$2.91 millionShort Interest Ratio / Days to Cover10.5Last Record DateApril 15, 2024Outstanding Shares37,584,000 sharesFloat Size14,910,000 sharesShort Percent of Float6.18%Today's Trading Volume6,615 sharesAverage Trading Volume98,319 sharesToday's Volume Vs. Average7% Short Selling Vigil Neuroscience ? Sign up to receive the latest short interest report for Vigil Neuroscience and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatVIGL Short Interest Over TimeVIGL Days to Cover Over TimeVIGL Percentage of Float Shorted Over Time Ad Crypto Swap ProfitsClaim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.Secure Your Spot Now Vigil Neuroscience Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/15/2024921,000 shares $2.91 million -6.8%6.2%10.5 $3.16 3/31/2024987,900 shares $3.37 million -5.0%7.1%10.9 $3.41 3/15/20241,040,000 shares $3.48 million +16.7%7.6%8.9 $3.35 2/29/2024891,100 shares $3.10 million +10.3%6.5%8.3 $3.48 2/15/2024807,800 shares $2.63 million +8.9%5.9%6.9 $3.25 1/31/2024742,000 shares $2.02 million +9.3%5.7%5.5 $2.72 Get the Latest News and Ratings for VIGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Vigil Neuroscience and its competitors with MarketBeat's FREE daily newsletter. 1/15/2024678,600 shares $2.23 million -9.2%5.2%5.2 $3.28 12/31/2023747,400 shares $2.53 million +19.0%5.8%5.9 $3.38 12/15/2023628,100 shares $2.26 million -8.9%4.8%6 $3.60 11/30/2023689,700 shares $2.19 million -14.9%5.3%7.4 $3.18 11/15/2023810,600 shares $5.40 million +5.1%6.3%10.2 $6.66 10/31/2023771,100 shares $5.40 million -8.0%6.1%17.4 $7.00 10/15/2023838,200 shares $4.90 million -3.5%6.6%19.3 $5.84 9/30/2023868,300 shares $4.68 million +7.3%6.8%17.6 $5.39 9/15/2023809,500 shares $5.50 million +3.0%6.4%16.3 $6.79 8/31/2023785,700 shares $4.74 million +8.8%5.4%9.7 $6.03 8/15/2023722,300 shares $4.22 million +31.7%4.9%8.8 $5.84 7/31/2023548,500 shares $4.46 million -24.0%3.8%6.9 $8.14 7/15/2023721,200 shares $6.74 million +4.5%5.0%9.5 $9.35 6/30/2023690,500 shares $6.49 million +45.2%4.8%9.9 $9.40 6/15/2023475,600 shares $4.76 million +0.1%3.3%7.1 $10.00 5/31/2023475,000 shares $4.75 million -14.6%3.3%16.4 $10.00 5/15/2023556,400 shares $4.80 million +4.4%3.9%22.8 $8.63 4/30/2023533,100 shares $4.64 million +5.7%3.7%23.9 $8.70 4/15/2023504,300 shares $4.80 million +9.5%3.5%25.1 $9.52 3/31/2023460,500 shares $4.51 million +2.8%3.2%22.8 $9.79 3/15/2023448,000 shares $3.98 million +4.8%3.9%20.3 $8.88 2/28/2023427,300 shares $5.13 million +0.5%3.7%14 $12.00 2/15/2023425,100 shares $4.89 million -1.1%3.0%13.1 $11.50 1/31/2023429,600 shares $4.66 million +7.0%3.3%12.2 $10.84 1/15/2023401,400 shares $4.80 million +1.6%3.1%10.9 $11.95 12/30/2022395,000 shares $4.94 million +29.5%3.0%10.4 $12.50 12/15/2022305,100 shares $3.82 million -0.2%2.3%8.7 $12.53 11/30/2022305,700 shares $3.82 million +8.2%2.3%12.5 $12.50 11/15/2022282,500 shares $3.11 million +1.2%2.2%13.3 $11.00 10/31/2022279,200 shares $4.38 million -4.7%2.7%16.8 $15.68 10/15/2022293,000 shares $4.68 million -1.7%2.8%17.3 $15.97 9/30/2022298,100 shares $2.71 million +0.2%N/A15.9 $9.10 9/15/2022297,600 shares $2.45 million -6.0%N/A7.1 $8.24 8/31/2022316,500 shares $2.72 million -2.8%N/A6.5 $8.60He Is Giving Away Bitcoin (Ad)And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here VIGL Short Interest - Frequently Asked Questions What is Vigil Neuroscience's current short interest? Short interest is the volume of Vigil Neuroscience shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 921,000 shares of VIGL short. 6.18% of Vigil Neuroscience's shares are currently sold short. Learn More on Vigil Neuroscience's current short interest. What is a good short interest ratio for Vigil Neuroscience? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. VIGL shares currently have a short interest ratio of 10.0. Learn More on Vigil Neuroscience's short interest ratio. What is a good short interest percentage for Vigil Neuroscience? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 6.18% of Vigil Neuroscience's floating shares are currently sold short. Is Vigil Neuroscience's short interest increasing or decreasing? Vigil Neuroscience saw a decrease in short interest during the month of April. As of April 15th, there was short interest totaling 921,000 shares, a decrease of 6.8% from the previous total of 987,900 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Vigil Neuroscience's float size? Vigil Neuroscience currently has issued a total of 37,584,000 shares. Some of Vigil Neuroscience's outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Vigil Neuroscience currently has a public float of 14,910,000 shares. How does Vigil Neuroscience's short interest compare to its competitors? 6.18% of Vigil Neuroscience's shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Vigil Neuroscience: bluebird bio, Inc. (29.83%), AlloVir, Inc. (5.57%), Curis, Inc. (1.01%), aTyr Pharma, Inc. (0.56%), Sangamo Therapeutics, Inc. (6.39%), BioAtla, Inc. (11.27%), Atara Biotherapeutics, Inc. (9.51%), Outlook Therapeutics, Inc. (7.41%), Passage Bio, Inc. (4.24%), Gritstone bio, Inc. (13.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.70 billion), Occidental Petroleum Co. ($3.52 billion), Charter Communications, Inc. ($3.14 billion), General Motors ($2.68 billion), Coinbase Global, Inc. ($2.57 billion), Moderna, Inc. ($2.18 billion), Tractor Supply ($2.10 billion), Royal Caribbean Cruises Ltd. ($1.91 billion), TC Energy Co. ($1.90 billion), and Williams-Sonoma, Inc. ($1.78 billion). View all of the most shorted stocks. What does it mean to sell short Vigil Neuroscience stock? Short selling VIGL is an investing strategy that aims to generate trading profit from Vigil Neuroscience as its price is falling. VIGL shares are trading up $0.59 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Vigil Neuroscience? A short squeeze for Vigil Neuroscience occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of VIGL, which in turn drives the price of the stock up even further. How often is Vigil Neuroscience's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including VIGL, twice per month. The most recent reporting period available is April, 15 2024. More Short Interest Resources from MarketBeat Related Companies: OMGA Short Interest LIFE Short Interest SGMO Short Interest DBVT Short Interest BLUE Short Interest VXRT Short Interest GRTS Short Interest MOLN Short Interest OTLK Short Interest CRDL Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:VIGL) was last updated on 5/9/2024 by MarketBeat.com Staff From Our PartnersTech GIANT’s Plans to Revolutionize Crypto…Crypto 101 MediaThis 1 Biotech Stock has been shocking the marketsHuge AlertsThe 2024 Gold Rush: Unleashing Market PotentialPriority GoldHe Is Giving Away BitcoinCrypto Swap ProfitsDems have chosen Biden replacement?Paradigm PressThe A.I. story nobody is telling you (Read ASAP)TradeSmithRich Dad Poor Dad Author Shocks Millions With 2024 Crash WarningAmerican Hartford Gold GroupUrgent Nvidia WarningAltimetry